Procter & Gamble Health

Procter & Gamble Health

6,581.50
+243.00
(3.83%)
Market Cap
10,924.88 Cr
EPS
141.00
PE Ratio
35.00
Dividend Yield
1.97 %
Industry
Healthcare
52 Week High
6,500.00
52 Week Low
4,863.00
PB Ratio
19.60
Debt to Equity
0.01
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Procter & Gamble Health Limited received stock exchange approval for reclassifying three erstwhile promoter shareholders - Emedia Export Company mit beschrankter Haftung, Chemitra Gesellschaft mit beschrankter Hafiung and Merck Internationale Beteiligungen GmbH - to public shareholders. Following this reclassification, Procter & Gamble Overseas India BV remains the sole promoter shareholder holding 51.82% stake, while public shareholders hold 48.18%. The company had originally applied for this reclassification in June 2018, with the approval taking effect from December 2018.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,641.80
#1 3,93,922.82
34.30
#1 54,729.00
9.71
#1 10,980
-19.84
47.84
6,151.50
1,63,303.00
69.37
9,712.00
18.67
2,191
26.74
42.63
1,592.80
1,28,651.70
23.86
28,409.50
7.12
5,291
9.88
66.07
3,685.30
1,24,727.30
61.13
11,539.40
6.99
1,911
19.91
62.55
2,606.80
1,07,590.13
56.78
12,744.20
#1 20.90
2,007
-18.14
60.80
1,277.60
1,06,624.80
#1 18.75
33,741.20
16.73
5,725
1.26
57.55
988.80
99,496.42
21.29
23,511.00
18.55
4,615
2.60
57.27
1,974.70
90,183.65
24.22
22,909.50
13.74
3,306
#1 51.64
55.21
31,875.00
67,732.15
47.71
6,684.70
9.64
1,414
11.55
39.14
5,426.00
64,875.97
28.51
13,458.30
3.70
2,216
21.39
70.80
Forecast
Actual
Growth Rate
Revenue Growth
-19.06 %
Net Income Growth
16.62 %
Cash Flow Change
-26.11 %
ROE
16.93 %
ROCE
13.19 %
EBITDA Margin (Avg.)
26.27 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
TTM
Revenue
963
1,017
722
873
1,425
1,027
1,128
1,248
1,167
945
1,287
Expenses
856
877
621
701
1,041
763
847
905
845
616
864
EBITDA
107
140
101
173
384
264
281
343
322
329
423
Operating Profit %
9 %
12 %
11 %
17 %
23 %
24 %
24 %
26 %
27 %
34 %
32 %
Depreciation
23
25
19
21
30
30
27
28
27
17
22
Interest
0
0
0
0
0
1
0
1
1
0
1
Profit Before Tax
83
115
99
158
355
233
253
314
273
312
400
Tax
30
36
38
56
101
57
61
85
72
77
101
Net Profit
54
79
61
102
254
177
193
230
201
234
301
EPS in ₹
32.30
47.70
56.60
505.27
153.00
107.00
116.00
138.00
121.00
141.00
181.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
Total Assets
784
879
991
1,760
1,176
986
888
1,101
794
794
Fixed Assets
132
111
115
104
101
104
112
144
129
116
Current Assets
572
636
752
1,534
954
727
608
796
524
526
Capital Work in Progress
7
30
9
17
22
39
41
33
6
11
Investments
42
28
70
0
0
0
0
0
0
0
Other Assets
603
711
797
1,639
1,053
843
736
925
660
667
Total Liabilities
784
879
991
1,760
1,176
986
888
1,101
794
794
Current Liabilities
165
186
225
193
227
239
232
304
219
215
Non Current Liabilities
27
29
33
27
42
44
40
46
37
42
Total Equity
592
664
733
1,540
906
704
617
751
538
537
Reserve & Surplus
575
647
717
1,524
890
687
600
734
522
520
Share Capital
17
17
17
17
17
17
17
17
17
17

Cash Flow

Cash Flow
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
Net Cash Flow
4
17
-16
1,109
-483
-172
-145
116
-197
-57
Investing Activities
-68
-75
-48
1,270
165
-32
-26
-22
-7
10
Operating Activities
84
107
54
-130
235
247
170
236
228
169
Financing Activities
-12
-15
-22
-30
-883
-387
-289
-99
-418
-235

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
7.59 %
6.24 %
6.40 %
6.61 %
7.02 %
6.87 %
6.99 %
DIIs
11.48 %
11.81 %
8.37 %
8.53 %
7.90 %
8.07 %
12.62 %
12.43 %
12.31 %
12.30 %
12.13 %
12.67 %
13.73 %
14.55 %
14.84 %
14.71 %
14.21 %
14.16 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.58 %
24.49 %
24.80 %
24.55 %
24.81 %
25.09 %
24.46 %
24.33 %
24.09 %
23.64 %
23.43 %
22.91 %
22.61 %
21.82 %
21.46 %
21.34 %
21.90 %
21.89 %
Others
12.13 %
11.88 %
15.01 %
15.10 %
15.47 %
15.02 %
11.11 %
11.43 %
11.78 %
12.25 %
12.62 %
5.02 %
5.60 %
5.41 %
5.28 %
5.12 %
5.21 %
5.14 %
No of Share Holders
0
53,075
58,818
63,525
65,537
66,289
65,729
65,148
61,030
58,856
57,919
56,730
56,778
55,923
54,792
53,736
53,993
52,478

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 11 15 440 0.00 230 130 52.5 95 260 125
Dividend Yield (%) 1.05 1 11.91 0.00 3.71 3.25 1.12 2.02 5.05 1.97

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 6,185.55 6,338.50
22 Aug 2025 DIVIDEND Dividend
₹ 45.00 /share
22 Aug 2025 5,729.50 6,338.50
06 May 2019 CHANGE OF NAME Change Of Name
NA
06 May 2019 3,672.50 3,672.50
05 Nov 2021 DIVIDEND Dividend
₹ 40.00 /share
02 Nov 2021 5,424.55 5,444.20
05 Nov 2021 DIVIDEND Dividend
₹ 90.00 /share
02 Nov 2021 5,374.30 5,444.20
13 May 2022 DIVIDEND Dividend
₹ 41.00 /share
12 May 2022 4,409.35 4,294.00
17 Nov 2022 DIVIDEND Dividend
₹ 11.50 /share
15 Nov 2022 4,190.70 4,290.60
23 Nov 2022 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Nov 2022 4,279.25 4,163.45
13 Feb 2023 DIVIDEND Dividend
₹ 45.00 /share
13 Feb 2023 4,096.95 4,702.90
24 Nov 2023 DIVIDEND Dividend
₹ 50.00 /share
23 Nov 2023 5,360.10 5,072.15
30 Nov 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Nov 2023 5,343.35 5,154.75
14 Feb 2024 DIVIDEND Dividend
₹ 50.00 /share
14 Feb 2024 5,136.60 5,503.95
14 Feb 2024 DIVIDEND Dividend
₹ 150.00 /share
14 Feb 2024 5,136.60 5,503.95
04 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Nov 2024 5,251.05 5,196.40
29 Nov 2024 DIVIDEND Dividend
₹ 60.00 /share
28 Nov 2024 5,422.90 5,168.55
05 Dec 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Dec 2024 5,373.45 5,346.85
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 5,446.35 5,259.70
21 Feb 2025 DIVIDEND Dividend
₹ 80.00 /share
21 Feb 2025 5,259.70 5,345.60
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 5,410.00 5,729.50
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 5,876.30 5,895.50

Announcements

Approval Of Promoter Reclassification Pursuant To Companys Application Dated June 27 20183 days ago
Record Date For Annual General MeetingAug 06, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 06, 2025
Annual Report For The Financial Year 2024-25 And Notice Calling The 58Th Annual General Meeting Of The CompanyAug 06, 2025
Press Release For The Quarter Ended June 30 2025Aug 01, 2025
Unaudited Financial Results For Quarter Ended June 30 2025Aug 01, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 27, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On August 1 2025Jun 27, 2025
Closure of Trading WindowJun 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 17, 2025
Analysts/Institutional Investors - PresentationJun 16, 2025
Change In Senior Management Personnel Of The Company Jun 11, 2025
Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health LimitedJun 09, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
Appointment Of Secretarial AuditorsMay 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
Corporate Action-Board approves DividendMay 29, 2025
Financial Results For The Year Ended March 312025May 29, 2025
Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Appointment Of Mr. Sharad Tyagi (DIN- 00371842) And Ms. Krishna Sarma (DIN00016115) As Non-Executive Independent Directors Of The Company For A Period Of Five YearsApr 10, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 10, 2025
Closure of Trading WindowMar 26, 2025
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 29 2025Mar 26, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 10, 2025
Integrated Filing (Financial)Feb 18, 2025
Communication With Respect To Tds On Dividend Income Declared By The CompanyFeb 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Appointment Of Chairperson Of The BoardFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Corporate Action-Board approves DividendFeb 12, 2025
Unaudited Financial ResultsFeb 12, 2025
Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25Feb 12, 2025
Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25Feb 12, 2025
Update on board meetingJan 31, 2025
Intimation Regarding Change Of The Financial Year Of The CompanyJan 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On February 12 2025Dec 27, 2024
Closure of Trading WindowDec 27, 2024
Change In Senior Management Personnel Of The CompanyDec 06, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMDec 06, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportDec 06, 2024
Proceedings Of The 57Th Annual General Meeting Of Shareholders Held On December 5, 2024Dec 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 21, 2024

Technical Indicators

RSI(14)
Neutral
63.27
ATR(14)
Volatile
181.84
STOCH(9,6)
Neutral
57.19
STOCH RSI(14)
Neutral
31.32
MACD(12,26)
Bearish
-0.68
ADX(14)
Strong Trend
28.73
UO(9)
Bearish
38.38
ROC(12)
Uptrend And Accelerating
2.68
WillR(14)
Neutral
-55.48

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
ICICI Prudential Smallcap Fund Direct Plan-Growth
2.74%
46925
0.35%
0.32%
Tata India Pharma & Healthcare Fund Direct-Growth
0.00%
-16000
-0.73%
-0.75%
UTI Balanced Advantage Fund Direct - Growth
0.30%
12615
0.25%
0.30%
HDFC BSE 500 Index Fund Direct - Growth
0.02%
-6
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.35%
-5
0.00%
-0.01%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct-Growth
2.79%
0
0.11%
0.03%
HDFC Retirement Savings Fund - Hybrid Equity Plan Direct-Growth
0.42%
0
0.00%
0.00%
ICICI Prudential Bharat Consumption Fund Direct - Growth
0.51%
0
-0.01%
0.01%
ICICI Prudential MNC Fund Direct - Growth
0.32%
0
0.00%
0.01%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.75%
0
-0.05%
-0.06%
DSP Healthcare Fund Direct - Growth
2.94%
0
-0.12%
-0.14%
Aditya Birla Sun Life MNC Fund Direct-Growth
1.09%
0
0.01%
0.00%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Quant Fund Direct-Growth
0.00%
0
0.00%
0.00%
Nippon India Small Cap Fund Direct- Growth
0.62%
0
0.01%
0.00%
Groww Nifty Total Market Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct - Growth
2.77%
0
0.11%
0.03%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct - Growth
2.99%
0
0.08%
0.00%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct - Growth
2.89%
0
0.07%
0.00%
Sundaram Long Term Tax Advantage Fund Series III Direct - Growth
3.00%
0
0.06%
-0.01%
Sundaram Long Term Tax Advantage Fund Series IV Direct - Growth
3.19%
0
0.04%
-0.06%
Sundaram Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
1.29%
0
-0.04%
-0.06%